Mayo Clinic Proceedings - Practical Considerations for the Diagnosis and Management of Asthma in Older Adults (November 1, 2017)
One of the premier peer-reviewed clinical journals in general and internal medicine, Mayo Clinic Proceedings is among the most widely read and highly cited scientific publications for physicians, with a circulation of approximately 125,000. Mayo Clinic Proceedings is published by Elsevier and sponsored by Mayo Clinic and the Mayo Foundation for Medical Education and Research. The mission of Mayo Clinic Proceedings is to promote the best interest of patients by advancing the knowledge and professionalism of the physician community. Since 2009 the Journal has offered CME credit for specific articles from both the Mayo Clinic for Concise Review for Clinicians and specially commissioned Symposia articles (comprehensive coverage on one topic).
Participation in this activity consists of reviewing articles and responding to a short online test. It is estimated that this activity will take approximately one hour per article. There is no charge for participating in this Journal CME activity.
To receive CME credit, please do the following:
- Click Take Course
- Complete quiz and evaluation (There is a required 80% pass rate in order to earn credit, with 1 retake allowed.)
- Print your Record of Attendance
The target audience for Mayo Clinic Proceedings is primarily internal medicine physicians and other clinicians who wish to advance their current knowledge of clinical medicine and who wish to stay abreast of advances in medical research.
On completion of this article, you should be able to (1) describe the characteristics of asthma in older adults; (2) list the goals of asthma management in older adults, and (3) state treatment options for effective management of asthma in older adults, including inhalation device considerations.
No relevant financial relationships:
Planning Committee, Editorial Board Members and Staff
Thomas J. Beckman, M.D.
Timothy B. Curry, M.D., Ph.D.
William L. Lanier, Jr., M.D.
Eric L. Matteson, M.D.
Karl A. Nath, M.D.
S. Vincent Rajkumar, M.D.
Kimberly D. Sankey
A. Keith Stewart, M.D.
Margaret (Peg) Wentz
Christopher M. Wittich, M.D.
Relevant financial relationships:
Editorial Board: Michelle Mauermann, M.D. - Consultant - IONIS Pharmaceuticals, Honoraria - Continuum
Off-label drugs: None.
AUTHORS DISCLOSURE SUMMARY:
Authors: Barbara P. Yawn, MD, MSc, MSPH; and MeiLan K. Han, MD, MS
Department of Family Medicine and Community Health, University of Minnesota, Minneapolis, MN (B.P.Y.); and Women’s Respiratory Clinic, Division of Pulmonary and Critical Care Medicine, University of Michigan Health System, Ann Arbor, MI (M.K.H.).
Financial Support and Conflict of Interest Disclosure: Dr Yawn has served as a consultant to Thermo Fischer Scientific related to allergy evaluation in asthma, a consultant to ndd Medical Technologies, Inc, related to spirometry use in asthma and chronic obstructive pulmonary disease in primary care, and as an advisory board member for Boehringer Ingelheim Pharmaceuticals, Inc, Novartis AG, and GlaxoSmithKline plc for asthma and chronic obstructive pulmonary disease; she has received free inhaled corticosteroid drugs from Teva Pharmaceutical Industries Ltd for patients enrolled in a Patient-Centered Outcomes Research Institute–funded trial for which she is a coinvestigator. Dr Han has served as a consultant for GlaxoSmithKline plc, Boehringer Ingelheim Pharmaceuticals, Inc, Sunovion Pharmaceuticals Inc, Novartis AG, and AstraZeneca related to asthma and chronic obstructive pulmonary disease and has received a bronchodilator drug from Novartis AG for patients enrolled in a National Institutes of Health–sponsored study for which she is principal investigator. The authors received no direct compensation related to the development of the submitted manuscript.
Grant Support: Writing support was provided by David Young of Young Medical Communications and Consulting Ltd, which was contracted and funded by Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc was given the opportunity to review the manuscript for medical and scientific accuracy as well as intellectual property considerations. The authors received no direct compensation related to the development of the submitted manuscript.
Off-label drugs: The authors do not discuss off-label/investigative uses(s) of drugs.
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Mayo Clinic College of Medicine and Science designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity enables the participant to earn up to 1 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.
Other Healthcare Professionals
A certificate of attendance will be provided to other healthcare professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here.
- 1.00 ABIM
- 1.00 AMA PRA Category 1 Credit™